Tag: #Global Trends

Italy's antitrust regulatory watchdog has formally initiated an official investigation into pharmaceutical manufacturer Biogen Italia and its U.S.-based parent corporation,... Read more

South Korean vaccine innovator SK bioscience has finalized a definitive technology transfer and manufacturing agreement with the Colombian government, enabling... Read more

More than three years after Gilead Sciences’ targeted hepatitis D virus (HDV) candidate bulevirtide was turned down by the U.S.... Read more

Specialty pharmaceutical manufacturer Sakar Healthcare has finalized a definitive supply agreement with Zydus Lifesciences to distribute its oncology product portfolio... Read more

Biopharmaceutical giant Eli Lilly is finalizing clinical preparations to launch a Phase 2 study for an investigational lipid-lowering gene-editing asset... Read more

South Korean drugmaker Hanmi Pharmaceutical has finalized a definitive supply agreement with global healthcare enterprise Organon to export three finished... Read more

One of the few publicly traded pharmaceutical heavyweights in Italy may soon transition to private ownership, following a definitive $12.4... Read more

Biopharmaceutical multinational Bristol Myers Squibb (BMS), historically recognized for its market leadership in oncology and cell therapies, is actively diversifying... Read more

Biopharmaceutical multinational Gilead Sciences has announced that its investigational formulation targeting a rare and severe liver infection has officially secured... Read more